Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386295950> ?p ?o ?g. }
- W4386295950 endingPage "e075429" @default.
- W4386295950 startingPage "e075429" @default.
- W4386295950 abstract "Despite growing awareness of neurodevelopmental impairments in children with congenital heart disease (CHD), there is a lack of large, longitudinal, population-based cohorts. Little is known about the contemporary neurodevelopmental profile and the emergence of specific impairments in children with CHD entering school. The performance of standardised screening tools to predict neurodevelopmental outcomes at school age in this high-risk population remains poorly understood. The NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) trial randomised 1371 children <2 years of age, investigating the effect of gaseous nitric oxide applied into the cardiopulmonary bypass oxygenator during heart surgery. The NITRIC follow-up study will follow this cohort annually until 5 years of age to assess outcomes related to cognition and socioemotional behaviour at school entry, identify risk factors for adverse outcomes and evaluate the performance of screening tools.Approximately 1150 children from the NITRIC trial across five sites in Australia and New Zealand will be eligible. Follow-up assessments will occur in two stages: (1) annual online screening of global neurodevelopment, socioemotional and executive functioning, health-related quality of life and parenting stress at ages 2-5 years; and (2) face-to-face assessment at age 5 years assessing intellectual ability, attention, memory and processing speed; fine motor skills; language and communication; and socioemotional outcomes. Cognitive and socioemotional outcomes and trajectories of neurodevelopment will be described and demographic, clinical, genetic and environmental predictors of these outcomes will be explored.Ethical approval has been obtained from the Children's Health Queensland (HREC/20/QCHQ/70626) and New Zealand Health and Disability (21/NTA/83) Research Ethics Committees. The findings will inform the development of clinical decision tools and improve preventative and intervention strategies in children with CHD. Dissemination of the outcomes of the study is expected via publications in peer-reviewed journals, presentation at conferences, via social media, podcast presentations and medical education resources, and through CHD family partners.The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry as 'Gene Expression to Predict Long-Term Neurodevelopmental Outcome in Infants from the NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) Study - A Multicentre Prospective Trial'.ACTRN12621000904875." @default.
- W4386295950 created "2023-08-31" @default.
- W4386295950 creator A5000448135 @default.
- W4386295950 creator A5001479406 @default.
- W4386295950 creator A5001968208 @default.
- W4386295950 creator A5004088030 @default.
- W4386295950 creator A5004577394 @default.
- W4386295950 creator A5005908657 @default.
- W4386295950 creator A5013061607 @default.
- W4386295950 creator A5016834022 @default.
- W4386295950 creator A5018750398 @default.
- W4386295950 creator A5024414476 @default.
- W4386295950 creator A5030369039 @default.
- W4386295950 creator A5030453858 @default.
- W4386295950 creator A5035603421 @default.
- W4386295950 creator A5035710891 @default.
- W4386295950 creator A5038778407 @default.
- W4386295950 creator A5043866435 @default.
- W4386295950 creator A5049833661 @default.
- W4386295950 creator A5051862930 @default.
- W4386295950 creator A5053138166 @default.
- W4386295950 creator A5056800509 @default.
- W4386295950 creator A5056977952 @default.
- W4386295950 creator A5058775884 @default.
- W4386295950 creator A5062434121 @default.
- W4386295950 creator A5062687683 @default.
- W4386295950 creator A5062747031 @default.
- W4386295950 creator A5063008596 @default.
- W4386295950 creator A5077258366 @default.
- W4386295950 creator A5079621286 @default.
- W4386295950 creator A5089371437 @default.
- W4386295950 creator A5089383047 @default.
- W4386295950 creator A5090048503 @default.
- W4386295950 creator A5090519392 @default.
- W4386295950 creator A5091468331 @default.
- W4386295950 creator A5092719381 @default.
- W4386295950 date "2023-08-01" @default.
- W4386295950 modified "2023-09-30" @default.
- W4386295950 title "Longitudinal cohort study investigating neurodevelopmental and socioemotional outcomes in school-entry aged children after open heart surgery in Australia and New Zealand: the NITRIC follow-up study protocol" @default.
- W4386295950 cites W1004010209 @default.
- W4386295950 cites W1909562790 @default.
- W4386295950 cites W1984810479 @default.
- W4386295950 cites W2002615900 @default.
- W4386295950 cites W2003419938 @default.
- W4386295950 cites W2008752887 @default.
- W4386295950 cites W2011059782 @default.
- W4386295950 cites W2033455893 @default.
- W4386295950 cites W2042273211 @default.
- W4386295950 cites W2047927055 @default.
- W4386295950 cites W2087859772 @default.
- W4386295950 cites W2088671127 @default.
- W4386295950 cites W2117564929 @default.
- W4386295950 cites W2159625444 @default.
- W4386295950 cites W2278422430 @default.
- W4386295950 cites W2317107191 @default.
- W4386295950 cites W2319887059 @default.
- W4386295950 cites W2351366439 @default.
- W4386295950 cites W2500742573 @default.
- W4386295950 cites W2590679164 @default.
- W4386295950 cites W2803215142 @default.
- W4386295950 cites W2809929769 @default.
- W4386295950 cites W2889638097 @default.
- W4386295950 cites W2904198424 @default.
- W4386295950 cites W2922045658 @default.
- W4386295950 cites W2958610596 @default.
- W4386295950 cites W2966949514 @default.
- W4386295950 cites W2982361452 @default.
- W4386295950 cites W3095690616 @default.
- W4386295950 cites W3096634627 @default.
- W4386295950 cites W3097244693 @default.
- W4386295950 cites W3159246460 @default.
- W4386295950 cites W3164857107 @default.
- W4386295950 cites W3189641274 @default.
- W4386295950 cites W3197684530 @default.
- W4386295950 cites W3201457928 @default.
- W4386295950 cites W349942210 @default.
- W4386295950 cites W4206004093 @default.
- W4386295950 cites W4213458387 @default.
- W4386295950 cites W4226288247 @default.
- W4386295950 cites W4283578215 @default.
- W4386295950 cites W4285498279 @default.
- W4386295950 cites W4294116629 @default.
- W4386295950 cites W4294129419 @default.
- W4386295950 cites W4295242423 @default.
- W4386295950 cites W653088284 @default.
- W4386295950 doi "https://doi.org/10.1136/bmjopen-2023-075429" @default.
- W4386295950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37648380" @default.
- W4386295950 hasPublicationYear "2023" @default.
- W4386295950 type Work @default.
- W4386295950 citedByCount "0" @default.
- W4386295950 crossrefType "journal-article" @default.
- W4386295950 hasAuthorship W4386295950A5000448135 @default.
- W4386295950 hasAuthorship W4386295950A5001479406 @default.
- W4386295950 hasAuthorship W4386295950A5001968208 @default.
- W4386295950 hasAuthorship W4386295950A5004088030 @default.
- W4386295950 hasAuthorship W4386295950A5004577394 @default.
- W4386295950 hasAuthorship W4386295950A5005908657 @default.
- W4386295950 hasAuthorship W4386295950A5013061607 @default.